Skip to main content
logo
Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China flag China · Delayed Price · Currency is CNY
5.53
+0.14 (2.60%)
Apr 30, 2026, 3:04 PM CST

SHE:002793 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
6,0145,0954,0555,8298,34215,181
Market Cap Growth
41.29%25.65%-30.44%-30.12%-45.05%-0.22%
Enterprise Value
6,5106,0555,3056,87611,05616,161
Last Close Price
5.534.803.825.367.6710.34
PE Ratio
-----37.38
PS Ratio
2.532.241.532.472.332.34
PB Ratio
5.124.122.782.272.523.21
P/TBV Ratio
8.456.664.542.933.003.76
P/FCF Ratio
28.9923.07-25.97--
P/OCF Ratio
25.2520.14-12.49-125.85
EV/Sales Ratio
2.742.662.002.913.082.50
EV/EBITDA Ratio
124.35163.70---22.90
EV/EBIT Ratio
-----31.10
EV/FCF Ratio
31.3827.41-30.63--
Debt / Equity Ratio
1.010.891.120.591.100.60
Debt / EBITDA Ratio
13.5624.12---3.97
Debt / FCF Ratio
5.754.97-6.77--
Net Debt / Equity Ratio
0.330.440.810.320.660.17
Net Debt / EBITDA Ratio
4.8614.70-4.16-2.86-1.561.17
Net Debt / FCF Ratio
1.862.46-4.333.68-1.91-4.37
Asset Turnover
0.620.560.560.360.410.75
Inventory Turnover
2.853.023.512.353.864.77
Quick Ratio
0.520.510.480.790.851.34
Current Ratio
0.760.840.701.081.081.59
Return on Equity (ROE)
-19.47%-21.11%-52.20%-26.16%-31.26%9.28%
Return on Assets (ROA)
-1.91%-2.46%-6.31%-4.53%-11.35%3.77%
Return on Invested Capital (ROIC)
-7.00%-7.17%-15.79%-10.81%-28.99%8.96%
Return on Capital Employed (ROCE)
-9.30%-11.10%-26.50%-15.00%-42.70%9.50%
Earnings Yield
-4.49%-5.66%-23.81%-11.34%-14.68%2.67%
FCF Yield
3.45%4.33%-6.74%3.85%-13.59%-1.24%
Dividend Yield
-----0.29%
Payout Ratio
-----32.59%
Buyback Yield / Dilution
-3.44%0.39%1.65%23.91%1.79%0.51%
Total Shareholder Return
-3.44%0.39%1.65%23.91%1.79%0.80%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.